RemSleep Holdings Files 10-Q Amendment

TL;DR

RemSleep Holdings filed a 10-Q amendment for Q1 2024. Check financials.

AI Summary

RemSleep Holdings Inc. filed an amendment (Amendment No. 1) to its Form 10-Q for the quarterly period ended March 31, 2024. The filing, dated May 29, 2024, provides updated information for the company, which is incorporated in Nevada and headquartered in Clearwater, Florida.

Why It Matters

This amendment indicates that RemSleep Holdings Inc. is providing updated financial and operational information for the first quarter of 2024, which is crucial for investors to assess the company's current performance.

Risk Assessment

Risk Level: low — This filing is a routine amendment to a quarterly report and does not appear to contain significant new negative information.

Key Players & Entities

• RemSleep Holdings Inc. (company) — Registrant
• March 31, 2024 (date) — Quarterly period end date
• May 29, 2024 (date) — Filing date
• Nevada (location) — State of incorporation
• Clearwater, Florida (location) — Business address

FAQ

Key Financial Figures

• $0 — mpany made cash payments to Mr. Lane of $0 and $ 12,000 , respectively. During th

Filing Documents

• ea0207044-10qa1_remsleep.htm (10-Q/A) — 392KB
• ea020704401ex4-1_remsleep.htm (EX-4.1) — 75KB
• ea020704401ex31-1_remsleep.htm (EX-31.1) — 10KB
• ea020704401ex32-1_remsleep.htm (EX-32.1) — 4KB
• 0001213900-24-047539.txt ( ) — 3386KB
• rmsl-20240331.xsd (EX-101.SCH) — 34KB
• rmsl-20240331_cal.xml (EX-101.CAL) — 31KB
• rmsl-20240331_def.xml (EX-101.DEF) — 176KB
• rmsl-20240331_lab.xml (EX-101.LAB) — 302KB
• rmsl-20240331_pre.xml (EX-101.PRE) — 175KB
• ea0207044-10qa1_remsleep_htm.xml (XML) — 255KB

- FINANCIAL INFORMATION

PART I. - FINANCIAL INFORMATION 1 Item 1.

Financial Statements

Financial Statements 1 Item 2.

Management's Discussion and Analysis of Financial Condition and Plan of Operations

Management's Discussion and Analysis of Financial Condition and Plan of Operations 2 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 5 Item 4

Controls and Procedures

Controls and Procedures 5

- OTHER INFORMATION

PART II - OTHER INFORMATION 6 Item 1.

Legal Proceedings

Legal Proceedings 6 Item 1A.

Risk Factors

Risk Factors 6 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 6 Item 3. Defaults Upon Senior Securities 6 Item 4. Mine Safety Disclosures 6 Item 5. Other Information 6 Item 6. Exhibits 6

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS REMSLEEP HOLDINGS, INC. Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023 (audited) F-1 of Operations for the Three Months Ended March 31, 2024 and 2023 (unaudited) F-2 of Changes in Stockholders' Equity (Deficit) for the Three Months Ended March 31, 2024 and 2023 (unaudited) F-3 of Cash Flows for the Three Months Ended March 31, 2024 and 2023 (unaudited) F-4 Notes to the Financial Statements (unaudited) F-5 1 REMSLEEP HOLDINGS, INC. BALANCE SHEETS March 31, 2024 December 31, 2023 ASSETS (Unaudited) (Audited) Current assets: Cash $ 730,625 $ 719,100 Accounts receivable, net of allowance of $ 5,590 and $ 5,590 , respectively 15,994 9,025 Other assets 12,000 8,710 Inventory 85,557 99,147 Total current assets 844,176 835,982 Other asset 10,000 10,000 Right of use asset 150,396 177,796 Property and equipment, net 154,976 182,536 Total Assets $ 1,159,548 $ 1,206,314 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current Liabilities: Accounts payable $ 14,000 $ 37,000 Accrued compensation 60,500 60,500 Convertible note payable, net of discount of $ 94,111 48,889 — Derivative liability 201,263 — Accrued interest 3,213 — Operating lease liability – current portion 138,659 134,438 Total current liabilities 466,524 231,938 Long Term Liabilities Operating lease liability – net of current portion 14,904 43,676 Total Liabilities 481,428 275,614 Commitments and Contingencies — — STOCKHOLDERS' EQUITY (DEFICIT): Series A preferred stock, $ 0.001 par value, 5,000,000 shares authorized, 5,000,000 and issued and outstanding 5,000 5,000 Series B preferred stock, $ 0.001 par value, 5,000,000 shares authorized, 500,000 shares issued 500 500 Series C preferred stock, $ 0.001 par value, 5,000,000 shares authorized, 2,000,000 issued and outstanding 2,000 2,000 Common stock, $ 0.00

View Full Filing

View this 10-Q/A filing on SEC EDGAR